Filtros : "Indexado no MEDLINE" "Emirados Árabes Unidos" Removido: "1927" Limpar

Filtros



Refine with date range


  • Source: Current Topics in Medicinal Chemistry. Unidades: FMVZ, FCF

    Subjects: PLANTAS MEDICINAIS, MEDICINA ALTERNATIVA, FITOQUÍMICA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RABELO, Ana Carolina Silveira et al. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications. Current Topics in Medicinal Chemistry, v. 23, n. 23, p. 2197-2213, 2023Tradução . . Disponível em: https://doi.org/10.2174/1568026623666230606162556. Acesso em: 15 nov. 2024.
    • APA

      Rabelo, A. C. S., Noratto, G. D., Borghesi, J., Fonseca, A. S., Cantanhede Filho, A. J., Carneiro, F. J. C., et al. (2023). Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications. Current Topics in Medicinal Chemistry, 23( 23), 2197-2213. doi:10.2174/1568026623666230606162556
    • NLM

      Rabelo ACS, Noratto GD, Borghesi J, Fonseca AS, Cantanhede Filho AJ, Carneiro FJC, Silva ALA, Miglino MA. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 23): 2197-2213.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1568026623666230606162556
    • Vancouver

      Rabelo ACS, Noratto GD, Borghesi J, Fonseca AS, Cantanhede Filho AJ, Carneiro FJC, Silva ALA, Miglino MA. Calotropis procera (Aiton) Dryand (Apocynaceae): state of the art of its use and applications [Internet]. Current Topics in Medicinal Chemistry. 2023 ; 23( 23): 2197-2213.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1568026623666230606162556
  • Source: Current Neuropharmacology. Unidades: FMRP, FCFRP, IRI

    Subjects: CANABINOIDES, INFLAMAÇÃO, TECIDO NERVOSO, DEGENERAÇÃO NEURAL, DOENÇAS DO SISTEMA NERVOSO, TRANSTORNOS PSICÓTICOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HARTMANN, Alice et al. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, v. 21, n. 2, p. 284-308, 2023Tradução . . Disponível em: https://doi.org/10.2174/1570159X20666220411101217. Acesso em: 15 nov. 2024.
    • APA

      Hartmann, A., Vila-Verde, C., Guimarães, F. S., Wegener, S. R. L. J., & Lisboa, S. F. de S. (2023). The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol. Current Neuropharmacology, 21( 2), 284-308. doi:10.2174/1570159X20666220411101217
    • NLM

      Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
    • Vancouver

      Hartmann A, Vila-Verde C, Guimarães FS, Wegener SRLJ, Lisboa SF de S. The NLRP3 inflammasome in stress response: another target for the promiscuous cannabidiol [Internet]. Current Neuropharmacology. 2023 ; 21( 2): 284-308.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1570159X20666220411101217
  • Source: Current Hypertension Reviews. Unidade: EERP

    Subjects: ANTIOXIDANTES, PRESSÃO SANGUÍNEA, HIPERTENSÃO, ESTRESSE OXIDATIVO, ESPÉCIES REATIVAS DE OXIGÊNIO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PINHEIRO, Lucas Cezar e OLIVEIRA-PAULA, Gustavo H. Sources and effects of oxidative stress in hypertension. Current Hypertension Reviews, v. 16, n. 3, p. 166-180, 2021Tradução . . Disponível em: https://doi.org/10.2174/1573402115666190531071924. Acesso em: 15 nov. 2024.
    • APA

      Pinheiro, L. C., & Oliveira-Paula, G. H. (2021). Sources and effects of oxidative stress in hypertension. Current Hypertension Reviews, 16( 3), 166-180. doi:10.2174/1573402115666190531071924
    • NLM

      Pinheiro LC, Oliveira-Paula GH. Sources and effects of oxidative stress in hypertension [Internet]. Current Hypertension Reviews. 2021 ; 16( 3): 166-180.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1573402115666190531071924
    • Vancouver

      Pinheiro LC, Oliveira-Paula GH. Sources and effects of oxidative stress in hypertension [Internet]. Current Hypertension Reviews. 2021 ; 16( 3): 166-180.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1573402115666190531071924
  • Source: Current Pharmaceutical Design. Unidades: FCFRP, ICB

    Subjects: CÉLULAS ENDOTELIAIS, ENDOTÉLIO VASCULAR, ÓXIDO NÍTRICO, FARMACOLOGIA, DOENÇAS VASCULARES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      PAULO, Michele et al. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, v. 26, n. 30, p. 3748-3759, 2020Tradução . . Disponível em: https://doi.org/10.2174/1381612826666200519114442. Acesso em: 15 nov. 2024.
    • APA

      Paulo, M., Costa, D. E. F. R., Bonaventura, D., Lunardi, C. N., & Bendhack, L. M. (2020). Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction. Current Pharmaceutical Design, 26( 30), 3748-3759. doi:10.2174/1381612826666200519114442
    • NLM

      Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1381612826666200519114442
    • Vancouver

      Paulo M, Costa DEFR, Bonaventura D, Lunardi CN, Bendhack LM. Nitric oxide donors as ootential drugs for the treatment of vascular diseases due to endothelium dysfunction [Internet]. Current Pharmaceutical Design. 2020 ; 26( 30): 3748-3759.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1381612826666200519114442
  • Source: Current Neuropharmacology. Unidade: FMRP

    Subjects: ALUCINOGÊNICOS, NEUROFARMACOLOGIA, TRANSTORNOS MENTAIS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HAMILL, Jonathan et al. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, v. 17, n. 2, p. 108-128, 2019Tradução . . Disponível em: https://doi.org/10.2174/1570159x16666180125095902. Acesso em: 15 nov. 2024.
    • APA

      Hamill, J., Hallak, J. E. C., Dursun, S. M., & Baker, G. (2019). Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness. Current Neuropharmacology, 17( 2), 108-128. doi:10.2174/1570159x16666180125095902
    • NLM

      Hamill J, Hallak JEC, Dursun SM, Baker G. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness [Internet]. Current Neuropharmacology. 2019 ; 17( 2): 108-128.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1570159x16666180125095902
    • Vancouver

      Hamill J, Hallak JEC, Dursun SM, Baker G. Ayahuasca: psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness [Internet]. Current Neuropharmacology. 2019 ; 17( 2): 108-128.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1570159x16666180125095902
  • Source: Current Drug Targets. Unidade: FMRP

    Subjects: HIPERTENSÃO, ÓXIDO NÍTRICO, NITRATOS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      OLIVEIRA-PAULA, Gustavo H. e TANUS-SANTOS, José Eduardo. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, v. 20, n. 4, p. 431-443, 2019Tradução . . Disponível em: https://doi.org/10.2174/1389450119666180816120816. Acesso em: 15 nov. 2024.
    • APA

      Oliveira-Paula, G. H., & Tanus-Santos, J. E. (2019). Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy. Current Drug Targets, 20( 4), 431-443. doi:10.2174/1389450119666180816120816
    • NLM

      Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1389450119666180816120816
    • Vancouver

      Oliveira-Paula GH, Tanus-Santos JE. Nitrite-stimulated gastric formation of S-nitrosothiols as an antihypertensive therapeutic strategy [Internet]. Current Drug Targets. 2019 ; 20( 4): 431-443.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1389450119666180816120816
  • Source: Current Topics in Medicinal Chemistry. Unidade: FCFRP

    Subjects: TRIPANOSSOMICIDAS, DOENÇAS DE CHAGAS, GLICOCONJUGADOS, TRYPANOSOMA CRUZI, VACINAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAMPO, Vanessa Leiria e MARCHIORI, Marcelo Fiori e CARVALHO, Ivone. Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, v. 18, n. 5, p. 382-396, 2018Tradução . . Disponível em: https://doi.org/10.2174/1568026618666180509145305. Acesso em: 15 nov. 2024.
    • APA

      Campo, V. L., Marchiori, M. F., & Carvalho, I. (2018). Insights into anti-trypanosomal agents based on synthetic glycoconjugates. Current Topics in Medicinal Chemistry, 18( 5), 382-396. doi:10.2174/1568026618666180509145305
    • NLM

      Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1568026618666180509145305
    • Vancouver

      Campo VL, Marchiori MF, Carvalho I. Insights into anti-trypanosomal agents based on synthetic glycoconjugates [Internet]. Current Topics in Medicinal Chemistry. 2018 ; 18( 5): 382-396.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1568026618666180509145305
  • Source: Current Vascular Pharmacology. Unidade: FMRP

    Subjects: HIPERTENSÃO, RATOS, ÓXIDO NÍTRICO, ANGIOTENSINA II

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WYNNE, Brandi M. et al. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice. Current Vascular Pharmacology, v. 16, n. 1, p. 93-101, 2018Tradução . . Disponível em: https://doi.org/10.2174/1570161115666170725151509. Acesso em: 15 nov. 2024.
    • APA

      Wynne, B. M., Labazi, H., Passaglia, R. de C. A. T., & Webb, R. C. (2018). Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice. Current Vascular Pharmacology, 16( 1), 93-101. doi:10.2174/1570161115666170725151509
    • NLM

      Wynne BM, Labazi H, Passaglia R de CAT, Webb RC. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice [Internet]. Current Vascular Pharmacology. 2018 ; 16( 1): 93-101.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1570161115666170725151509
    • Vancouver

      Wynne BM, Labazi H, Passaglia R de CAT, Webb RC. Nitroxyl anion mediates relaxation in mesenteric arteries from angiotensin II hypertensive mice [Internet]. Current Vascular Pharmacology. 2018 ; 16( 1): 93-101.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1570161115666170725151509
  • Source: Endocrine, Metabolic & Immune Disorders-Drug Targets. Unidades: EERP, FMRP

    Subjects: CHOQUE SÉPTICO, CITOCINAS, ÓXIDO NÍTRICO

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CÁRNIO, Evelin Capellari et al. Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release. Endocrine, Metabolic & Immune Disorders-Drug Targets, v. 6, n. 2, p. 7-16, 2006Tradução . . Acesso em: 15 nov. 2024.
    • APA

      Cárnio, E. C., Moreto, V., Giusti-Paiva, A., & Antunes-Rodrigues, J. (2006). Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release. Endocrine, Metabolic & Immune Disorders-Drug Targets, 6( 2), 7-16.
    • NLM

      Cárnio EC, Moreto V, Giusti-Paiva A, Antunes-Rodrigues J. Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release. Endocrine, Metabolic & Immune Disorders-Drug Targets. 2006 ; 6( 2): 7-16.[citado 2024 nov. 15 ]
    • Vancouver

      Cárnio EC, Moreto V, Giusti-Paiva A, Antunes-Rodrigues J. Neuro-immune-endocrine mechanisms during septic shock: role for nitric oxide in vasopressin and oxytocin release. Endocrine, Metabolic & Immune Disorders-Drug Targets. 2006 ; 6( 2): 7-16.[citado 2024 nov. 15 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024